SAN CARLOS, Calif.-- October 14, 2026 -- Altay Therapeutics, Inc., a biotechnology company developing novel small molecule inhibitors of transcription factors, today announced the completion of a $37 million Series...

Pappas Capital, LLC
5 Laboratory Drive
Suite 2225
Research Triangle Park, NC 27709
Mailing Address
P. O. Box 110287
Research Triangle Park, NC 27709
Tel: 919-998-3300
Fax: 919-998-3301